Submitted by Anonymous (not verified) on 11 January 2024 - 14:38
Human medicines European public assessment report (EPAR): Flebogamma DIF (previously Flebogammadif), human normal immunoglobulin, Date of authorisation: 23/07/2007, Revision: 19, Status: Authorised
Source: